Latest Prescription drug costs News
$3.5M gene therapy for hemophilia gets FDA approval
WASHINGTON (AP) — U.S. health regulators on Tuesday approved the first gene therapy for hemophilia, a $3.5 million one-time treatment for the blood-clotting disorder. The Food and Drug Administration cleared Hemgenix, an IV treatment for adults with hemophilia B, the less common...
Biogen tabs veteran pharma leader Viehbacher as next CEO
Biogen has picked former Sanofi CEO Christopher Viehbacher to become its next leader, as the drug developer continues to recover from its failed launch of the Alzheimer’s treatment Aduhelm. The company said Thursday that the 62-year-old Viehbacher will become president and CEO on...
New Hampshire Democrats Pappas, Kuster reelected to Congress
CONCORD, N.H. (AP) — Democrats Annie Kuster and Chris Pappas both won reelection to Congress in New Hampshire’s 1st and 2nd Districts, defeating two pro-Trump Republicans. Pappas defeated Karoline Leavitt, who worked in the White House press office under former President Donald...
